10x Genomics (NASDAQ:TXG – Free Report) had its price objective trimmed by Stifel Nicolaus from $63.00 to $53.00 in a report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities analysts have also recently issued research reports about the stock. Canaccord Genuity Group reduced their price target […]
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target decreased by equities research analysts at Stifel Nicolaus from $63.00 to $53.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target indicates a potential upside of 103.85% from the […]
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $26.48 and last traded at $26.62, with a volume of 131771 shares. The stock had previously closed at $27.52. Analysts Set New Price Targets TXG has been the […]
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $37.37, but opened at $35.33. 10x Genomics shares last traded at $35.56, with a volume of 47,155 shares trading hands. Analyst Ratings Changes TXG has been the topic of several recent […]
Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The […]